The C.R. Bard Avaulta vaginal mesh implanted to treat pelvic organ prolapse may put women at risk for internal injuries and urinary problems. Bard Avaulta mesh lawsuits allege that the defective design of the device may increase the risk of infection, erosion and other painful complications. Plaintiffs seek damages from C. R. Bard, Inc., which makes and sells Avaulta Plus and Avaulta Solo synthetic surgical mesh tissue supports.
Women suffer from pelvic organ prolapse often after childbirth or surgery. Pelvic organ prolapse affects a woman when organs near the pelvis drop from their normal position and put pressure on the vagina. Mesh products have been designed to address problems that stem from prolapse, which include difficulties with bowel and bladder functions or during sex.
The Bard Avaulta vaginal mesh lawsuits allege that the vaginal slings were negligently designed, causing pain and other complications. The problem for many vaginal mesh users has been an erosion of the mesh into the vaginal wall causing tearing, cutting, and sometimes permanent erosion of the vaginal tissues.